Aurel M. Toma

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMI.

Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMI.

Journal: Scientific reports

Published: March 10, 2026

Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial.

Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: December 22, 2025

Outcomes of durable versus biodegradable polymer drug-eluting stents in patients with coronary artery disease.

Outcomes of durable versus biodegradable polymer drug-eluting stents in patients with coronary artery disease.

Journal: International journal of cardiology. Heart & vasculature

Published: November 25, 2025

Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention.

Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: June 05, 2025

Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.

Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.

Journal: The New England journal of medicine

Published: August 27, 2023

Prognostic Value of Different Levels of Uric Acid in Patients with Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention.

Prognostic Value of Different Levels of Uric Acid in Patients with Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention.

Journal: Journal of clinical medicine

Published: March 12, 2023

Cardiopulmonary Long-Term Sequelae in Patients after Severe COVID-19 Disease.

Cardiopulmonary Long-Term Sequelae in Patients after Severe COVID-19 Disease.

Journal: Journal of clinical medicine

Published: January 23, 2023

New ECG algorithms with improved accuracy for prediction of culprit vessel in inferior ST-segment elevation myocardial infarction.

New ECG algorithms with improved accuracy for prediction of culprit vessel in inferior ST-segment elevation myocardial infarction.

Journal: Panminerva medica

Published: November 11, 2021

Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Journal: Frontiers in cardiovascular medicine

Published: June 21, 2021

Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.

Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.

Journal: Journal of the American College of Cardiology

Published: March 19, 2021

von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo.

von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo.

Journal: Thrombosis and haemostasis

Published: July 18, 2020

Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS.

Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS.

Journal: Platelets

Published: June 06, 2020

Showing 1-12 of 61

Last Updated: 09/26/2026